What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in ...

SALT LAKE CITY, April 06, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has entered into a ...

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12% ...

--Myriad Genetics, Inc.,, a leader in genetic testing and precision medicine, today announced its support for a recent guideline update by the American College of Medical Genetics and Genomics ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler analysts upgraded the stock's rating from Neutral to Buy. The ...

--Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today announced the addition of Folate Receptor Alpha to its Precise™ Oncology Solutions portfolio. "FRα, alongside ...

LONDON (MarketWatch) -- Myriad Genetics Inc. said a Phase 2 follow-on trial suggests its Flurizan drug continues to demonstrate increased benefit for ...

SALT LAKE CITY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the addition of five senior ...

About Myriad Genetics Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.

Drug stocks climb in afternoon action as shares of Myriad Genetics rebound from a sell-off in the previous session over its move to discontinue development ...

Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance May 06, 2025 4:05 PM ET Myriad Genetics, Inc. (MYGN) ...

A new national survey from Myriad Genetics, the GeneSight Mental Health Monitor, finds while nearly all Americans (94%) agree that substance and behavioral addictions often mask underlying mental ...